Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daylight PDT with Aminolevulinic Acid for Actinic Keratoses
NCT03327831Phase 4Completed
- Sponsor
- University of California, Irvine
- Start
- Apr 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aminolevulinic acid 10% gel in actinic keratosis (AK), sponsored by University of California, Irvine. Started Apr 2015; status: completed.
02
Drugs
aminolevulinic acid 10% gel
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT03327831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03327831.